Who Paid My Doc
Proquad
Biological Vaccine
NDC 0006-4999-00
General payments
$437,669
Research payments
$5,903
Through program year 2025, $437,669 in general payments and $5,903 in research payments were reported against Proquad (Vaccine).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $79,683 | 2,522 |
| 2025 | Research | $1,470 | 1 |
| 2024 | General | $87,235 | 3,961 |
| 2023 | General | $120,827 | 6,375 |
| 2022 | General | $133,346 | 7,796 |
| 2022 | Research | $663 | 1 |
| 2021 | General | $2,716 | 162 |
| 2021 | Research | $1,083 | 1 |
| 2020 | General | $1,738 | 115 |
| 2020 | Research | $730 | 3 |
| 2019 | General | $12,125 | 364 |
| 2019 | Research | $1,957 | 4 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 53 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
21,295 general · 10 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.